Explore more publications!

Press Releases

Outlook Therapeutics Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks
Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases
Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
Equifruit helps Pattison Food Group elevate banana offering with organic Fairtrade
Unique Global Innovative Solutions Corp. (UGIZ) Announces Strategic Spin-Off of Food Division and Special Stock Dividend to Shareholders
Nature Medicine Publishes Helus Pharma’s Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder
Cytokinetics Announces European Commission Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer
Organic Aromas Launches Industry-First Smart Nebulizing Diffuser Line With Bluetooth App Control
Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser
Drivers and Analysis of the Palm Oil Market by Application, Industry, Region, and Segment with Forecast to 2030
DevSecOps Market Industry Strengthens as Innovation and Capital Investments Rise | Aqua Security Software Ltd, Fortinet
Why Corporate Wellness Is a Must-Invest Market Now: USD 138.37 Bn Growth Reshaping Workplace Health
MTY Food Group Inc Will Hold a Conference Call to Discuss its 2025 Fourth Quarter and Year End Results
Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with  Alkem Laboratories Ltd.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions